Since it has been reported that cancer-associated mesothelial cells that colonize the peritoneum produce fibronectin [86], able to trap HGF produced by the fibroblasts of the tumor microenvironment [106], the inhibition of c-MET activation seems to be a promising target to block cancer metastasis. This evidence concerns the gene MET and neoplasm.